CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle ...

A team of researchers led by Professor Akitsu Hotta (Department of Clinical Application) developed a comprehensive framework ...

With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and ...

From gene-editing breakthroughs to blockbuster cystic fibrosis drugs, these two industry leaders present sharply contrasting ...

When standard leukaemia treatments failed, 13-year-old Alyssa Tapley was told she had only weeks left – but then she was ...

The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.

Researchers have made many modifications to the CRISPR system since it was first developed. CRISPR is a DNA-editing tool that usually uses an enzyme known as Cas9, which can cut genomic DNA. This Cas9 ...

We have identified the gene that, when activated, initiates the developmental programme that results in cells forming a human ...

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...